Kristin Berry
Overview
Explore the profile of Kristin Berry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ioannou G, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, et al.
Ann Intern Med
. 2025 Feb;
PMID: 39903865
Background: Monovalent COVID-19 vaccines targeting the XBB.1.5 Omicron variant were introduced in September 2023. In the absence of randomized controlled trials demonstrating their efficacy, information on real-world vaccine effectiveness (VE)...
2.
Bajema K, Bui D, Yan L, Li Y, Rajeevan N, Vergun R, et al.
JAMA Intern Med
. 2025 Jan;
185(3):324-334.
PMID: 39869355
Importance: SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) contribute to many hospitalizations and deaths each year. Understanding relative disease severity can help to inform vaccination guidance. Objective: To compare disease...
3.
Bajema K, Yan L, Li Y, Argraves S, Rajeevan N, Fox A, et al.
Lancet Infect Dis
. 2025 Jan;
PMID: 39848264
Background: New respiratory syncytial virus (RSV) vaccines have been approved in the USA for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 years and older. Information...
4.
Vutien P, Barnard Giustini A, Kim N, Moon A, Hsu C, Mezzacappa C, et al.
Hepatology
. 2024 Dec;
PMID: 39689352
Background And Aims: Recently proposed "Rule-of-Five" criteria define compensated advanced chronic liver disease (cACLD) and clinically significant portal hypertension (CSPH) using liver stiffness (LS) and platelet count. We aimed to...
5.
Bui D, Bajema K, Huang Y, Yan L, Li Y, Rajeevan N, et al.
PLoS One
. 2024 Oct;
19(10):e0307235.
PMID: 39365775
Objective: The epidemiology of COVID-19 has substantially changed since its emergence given the availability of effective vaccines, circulation of different viral variants, and re-infections. We aimed to develop models to...
6.
Yan L, Bui D, Li Y, Rajeevan N, Rowneki M, Berry K, et al.
Clin Infect Dis
. 2024 Jun;
79(3):643-651.
PMID: 38864601
Background: Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus disease 2019 (COVID-19) but remains underutilized. Information on which eligible groups are likely to benefit from treatment is needed....
7.
Vutien P, Kim N, Moon A, Johnson K, Berry K, Green P, et al.
Aliment Pharmacol Ther
. 2024 Jan;
59(3):419-420.
PMID: 38197705
No abstract available.
8.
Vutien P, Kim N, Moon A, Johnson K, Berry K, Green P, et al.
Aliment Pharmacol Ther
. 2023 Nov;
59(3):361-371.
PMID: 37955206
Background: It is unclear whether the risk of hepatocellular carcinoma (HCC) decreases over time following hepatitis C virus (HCV) eradication. Aim: To determine if patients who have accrued longer time...
9.
Ioannou G, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, et al.
Ann Intern Med
. 2023 Oct;
176(11):1486-1497.
PMID: 37903369
Background: COVID-19 has been linked to the development of many post-COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral antivirals used to treat acute...
10.
Hynes D, Niederhausen M, Chen J, Shahoumian T, Rowneki M, Hickok A, et al.
J Gen Intern Med
. 2023 Oct;
39(4):626-635.
PMID: 37884839
Background: Negative mental health-related effects of SARS-COV-2 infection are increasingly evident. However, the impact on suicide-related outcomes is poorly understood, especially among populations at elevated risk. Objective: To determine risk...